Residents in China have been scouring the market for generic COVID-19 drugs and India seems to be the answer to their problem. In the recent past, the Chinese authorities have approved two Covid antivirals – Pfizer’s Paxlovid and Azvudine – for the treatment. While China has ran out of the medicine, the Indian market is filled with it and is slowly becoming the next favourite destination.
In the past few months, topics like “anti-Covid Indian generic drugs sold at 1,000 yuan (US$144) per box” has been making the rounds of the Chinese social media. Platforms like Weibo and WeChat are filled with such queries and experts believe that black market deals are being conducted on them.
While the distribution of drugs which are not approved in China is not illegal, there can be penalties imposed on the illegal imports. Even the doctors in China have warned the public against buying drugs on the black market with several patients displaying massive side effects to the medicines.
Categories: Economy, Health, India, law and order, News Update